UCP2-Related mitochondrial pathway participates in oroxylin A-Induced apoptosis in human colon cancer cells

Journal of Cellular Physiology

Volumn 230, Issue 5, 2015, Pages 1054-1063

  Qiao, Chen ^a   Wei, Libin ^a   Dai, Qinsheng ^a   Zhou, Yuxin ^a   Yin, Qian ^a   Li, Zhiyu ^a   Xiao, Yuanming ^b   Guo, Qinglong ^a   Lu, Na ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Nanjing Foreign Language School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OROXYLIN A; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCOUPLING PROTEIN 2; 5,7-DIHYDROXY-6-METHOXY-2-PHENYLCHROMEN-4-ONE; CARRIER PROTEIN; FLAVONOID; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2;

APOPTOSIS; ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANTAGONISTS AND INHIBITORS; CACO 2 CELL LINE; CHEMISTRY; COLON TUMOR; DRUG EFFECTS; DRUG SCREENING; HCT116 CELL LINE; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

SCUTELLARIA BAICALENSIS;

APOPTOSIS; CACO-2 CELLS; COLONIC NEOPLASMS; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HCT116 CELLS; HUMANS; ION CHANNELS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84921668291     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24833     Document Type: Article

References (37)

1. Antonsson B. 2004. Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem 256-257:141-155.
2. Brand MD. 2000. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol 35:811-820.
3. Brand MD, Esteves TC. 2005. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2:85-93.
4. Dalla Pozza E, Fiorini C, Dando I, Menegazzi M, Sgarbossa A, Costanzo C, Palmieri M, Donadelli M. 2012. Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine. Biochim Biophys Acta 1823:1856-1863.
5. Dando I, Fiorini C, Pozza ED, Padroni C, Costanzo C, Palmieri M, Donadelli M. 2013. UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. Biochim Biophys Acta 1833:672-679.
6. Deng S, Yang Y, Han Y, Li X, Wang X, Zhang Z, Wang Y. 2012. UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions. PloS One 7:e30714.
7. Derdak Z, Fulop P, Sabo E, Tavares R, Berthiaume EP, Resnick MB, Paragh G, Wands JR, Baffy G. 2006. Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-kappaB activation and oxidative stress. Carcinogenesis 27:956-961.
8. Derdak Z, Garcia TA, Baffy G. 2009. Detection of uncoupling protein-2 (UCP2) as a mitochondrial modulator of apoptosis. Methods Mol Biol 559:205-217.
9. Derdak Z, Mark NM, Beldi G, Robson SC, Wands JR, Baffy G. 2008. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res 68:2813-2819.
10. Fulda S. 2010. Modulation of apoptosis by natural products for cancer therapy. Planta Med 76:1075-1079.
11. Fulda S, Galluzzi L, Kroemer G. 2010. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447-464.
12. Fulop P, Derdak Z, Sheets A, Sabo E, Berthiaume EP, Resnick MB, Wands JR, Paragh G, Baffy G. 2006. Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. Hepatology 44:592-601.
13. Gogvadze V, Orrenius S, Zhivotovsky B. 2009a. Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 19:57-66.
14. Gogvadze V, Orrenius S, Zhivotovsky B. 2009b. Mitochondria as targets for chemotherapy. Apoptosis 14:624-640.
15. Hui H, Chen Y, Yang H, Zhao K, Wang Q, Zhao L, Wang X, Li Z, Lu N, Guo Q. 2014. Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARgamma and RXRalpha. Int J Cancer 134:1195-1206.
16. Kang M, Li S, Zhong D, Yang Z, Li P. 2013. [Hepatocyte apoptosis and mitochondrial permeability transition pore opening in rats with nonalcoholic fatty liver]. Nan Fang Yi Ke Da Xue Xue Bao 33:1062-1066.
17. Kinnally KW, Antonsson B. 2007. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 12:857-868.
18. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC. 2004. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427:461-465.
19. Kroemer G, Reed JC. 2000. Mitochondrial control of cell death. Nat Med 6:513-519.
20. Kuai XY, Ji ZY, Zhang HJ. 2010. Mitochondrial uncoupling protein 2 expression in colon cancer and its clinical significance. World J Gastroenterol: WJG 16:5773-5778.
21. Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY. 2005. Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 96:1200-1207.
22. Li HB, Chen F. 2005. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A 1074:107-110.
23. Liu W, Mu R, Nie FF, Yang Y, Wang J, Dai QS, Lu N, Qi Q, Rong JJ, Hu R, Wang XT, You QD, Guo QL. 2009. MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells. Cancer Lett 284:198-207.
24. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157.
25. Mailloux RJ, Harper ME. 2011. Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med 51:1106-1115.
26. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie ZH, Reed JC, Kroemer G. 1998. The permeability transition pore complex: A target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187:1261-1271.
27. Mathupala SP, Guthikonda M, Sloan AE. 2006a. RNAi based approaches to the treatment of malignant glioma. Technol Cancer Res Treat 5:261-269.
28. Mathupala SP, Ko YH, Pedersen PL. 2006b. Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25:4777-4786.
29. McCommis KS, Baines CP. 2012. The role of VDAC in cell death: Friend or foe. Biochim Biophys Acta 1818:1444-1450.
30. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. 2005. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652-658.
31. Pfefferle A, Mailloux RJ, Adjeitey CN, Harper ME. 2013. Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeutics. Biochim Biophys Acta 1833:80-89.
32. Rose G, Crocco P, De Rango F, Montesanto A, Passarino G. 2011. Further support to the uncoupling-to-survive theory: The genetic variation of human UCP genes is associated with longevity. PloS One 6:e29650.
33. Suh DH, Kim MK, Kim HS, Chung HH, Song YS. 2013. Mitochondrial permeability transition pore as a selective target for anti-cancer therapy. Front Oncol 3:41.
34. Wei L, Dai Q, Zhou Y, Zou M, Li Z, Lu N, Guo Q. 2013. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II. Biochim Biophys Acta 1830:3835-3845.
35. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC. 2005. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305.
36. Zhao L, Chen Z, Wang J, Yang L, Zhao Q, Wang J, Qi Q, Mu R, You QD, Guo QL. 2010. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. Cancer Chemother Pharmacol 65:481-489.
37. Zhu L, Zhao L, Wang H, Wang Y, Pan D, Yao J, Li Z, Wu G, Guo Q. 2013. Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. Toxicol Lett 219:107-115.